Canopy Growth Corp Stock Today
| WEED Stock | CAD 4.38 0.06 1.39% |
Performance0 of 100
| Odds Of DistressOver 85
|
Canopy Growth is selling at 4.38 as of the 18th of December 2024; that is 1.39% increase since the beginning of the trading day. The stock's open price was 4.32. Canopy Growth has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 18th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. Canopy Growth Corporation is headquartered in Smiths Falls, Canada. The company has 122.39 M outstanding shares of which 2.49 M shares are at this time shorted by private and institutional investors with about 1.1 days to cover all short positions. More on Canopy Growth Corp
Moving together with Canopy Stock
Moving against Canopy Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Canopy Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Canopy Growth's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Canopy Growth or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | David Klein | ||||
| Thematic Idea | Cannabis (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Cannabis, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
Canopy Growth's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Canopy Growth's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCanopy Growth can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Canopy Growth's financial leverage. It provides some insight into what part of Canopy Growth's total assets is financed by creditors.
| |||||
Canopy Growth Corp (WEED) is traded on Toronto Exchange in Canada and employs 1,029 people. Canopy Growth is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 642.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Canopy Growth's market, we take the total number of its shares issued and multiply it by Canopy Growth's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Canopy Growth Corp operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 122.39 M outstanding shares of which 2.49 M shares are at this time shorted by private and institutional investors with about 1.1 days to cover all short positions.
Canopy Growth Corp has accumulated about 214.55 M in cash with (281.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.54, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Canopy Growth Probability Of Bankruptcy
Ownership AllocationCanopy Growth holds a total of 122.39 Million outstanding shares. Almost 91.83 percent of Canopy Growth outstanding shares are held by general public with 0.17 (percent) owned by insiders and only 8.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Canopy Ownership Details
Canopy Growth Corp Risk Profiles
Although Canopy Growth's alpha and beta are two of the key measurements used to evaluate Canopy Growth's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.32 | |||
| Standard Deviation | 4.97 | |||
| Variance | 24.7 | |||
| Risk Adjusted Performance | (0.07) |
Canopy Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Canopy Growth without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Canopy Growth Corporate Management
Elected by the shareholders, the Canopy Growth's board of directors comprises two types of representatives: Canopy Growth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Canopy. The board's role is to monitor Canopy Growth's management team and ensure that shareholders' interests are well served. Canopy Growth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Canopy Growth's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Ware | Chief Medical Officer | Profile | |
| Judy Hong | Chief Intelligence | Profile | |
| Terry Yanofsky | Director | Profile | |
| FCPA FCA | Strategic Advisor | Profile | |
| Robert Hanson | Independent Director | Profile | |
| Christelle LLB | Chief Secretary | Profile |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Canopy Growth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.